Lower Rates of Emergency Department Visits and Hospitalizations Among Patients With Chronic Hepatitis C With
Stuart C Gordon1,2, Eyasu H Teshale3, Philip R Spradling3
1Department of Gastroenterology and Hepatology, Henry Ford Health System, Detroit Michigan, USA.
Insights
Patients with hepatitis C virus (HCV) achieving sustained virological response after direct-acting antiviral therapy had fewer emergency department visits and hospitalizations. This demonstrates the significant health benefits of successful HCV treatment.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis C virus (HCV) infection poses a significant global health burden.
- Direct-acting antiviral (DAA) therapies have revolutionized HCV treatment, leading to high rates of sustained virological response (SVR).
- Understanding the long-term impact of SVR on healthcare utilization is crucial for resource planning and patient management.
Purpose of the Study:
- To compare the rates of emergency department (ED) visits and hospitalizations between HCV patients who achieved SVR after DAA therapy and matched controls.
- To assess the impact of successful HCV treatment on liver-related and all-cause healthcare utilization.
Main Methods:
- A retrospective cohort study design was employed.
- 3049 pairs of patients achieving SVR after DAA therapy (case patients) and matched controls were analyzed.
- Rates of liver-related ED visits, all-cause hospitalizations, liver-related hospitalizations, and hospitalized days were compared between groups.
Main Results:
- Case patients showed significantly lower rates of liver-related ED visits compared to controls (P = .01).
- All-cause hospitalization rates, liver-related hospitalization rates, and the number of hospitalized days were significantly lower in case patients (P < .001).
Conclusions:
- Achieving sustained virological response after direct-acting antiviral therapy for hepatitis C virus is associated with reduced healthcare utilization.
- Successful HCV treatment leads to decreased emergency department visits and hospitalizations, highlighting the clinical and economic benefits of DAA therapy.
Abstract:
We compared rates of emergency department visits and hospitalizations between patients with hepatitis C virus who achieved sustained virological response after direct-acting antiviral therapy (case patients) and matched controls. Among 3049 pairs, case patients demonstrated lower rates of liver-related emergency department visits (P = .01) than controls; all-cause and liver-related hospitalization rates and number of hospitalized days were also lower in case patients (P < .001).
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Retrovirus Life Cycles
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Drug Excretion: Influencing Factors
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...


